C. Irwin

410 total citations
10 papers, 305 citations indexed

About

C. Irwin is a scholar working on Molecular Biology, Dermatology and Oncology. According to data from OpenAlex, C. Irwin has authored 10 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Dermatology and 3 papers in Oncology. Recurrent topics in C. Irwin's work include Ovarian cancer diagnosis and treatment (3 papers), Cancer-related Molecular Pathways (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). C. Irwin is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Cancer-related Molecular Pathways (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). C. Irwin collaborates with scholars based in United Kingdom, United States and Jordan. C. Irwin's co-authors include Robert M. Lavker, G. Frank Gerberick, Kays H. Kaidbey, T. P. Rollason, H. F. Hope-Stone, Julia E. Palmer, Alan Morris, Anthony Neal, Sridhar Chaganti and Julia Scarisbrick and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and British Journal of Radiology.

In The Last Decade

C. Irwin

9 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Irwin United Kingdom	7	214	57	41	36	34	10	305
Angela Tewari United Kingdom	8	260 1.2×	65 1.1×	55 1.3×	55 1.5×	51 1.5×	20	357
S. Gaskell United Kingdom	7	244 1.1×	79 1.4×	39 1.0×	56 1.6×	25 0.7×	9	320
Bert‐Jan Vermeer Netherlands	9	204 1.0×	121 2.1×	25 0.6×	37 1.0×	21 0.6×	12	288
Norval United Kingdom	5	209 1.0×	46 0.8×	31 0.8×	20 0.6×	26 0.8×	5	311
P Schroeder Germany	12	98 0.5×	34 0.6×	33 0.8×	49 1.4×	18 0.5×	41	457
James L. Griffith United States	11	190 0.9×	119 2.1×	21 0.5×	29 0.8×	7 0.2×	20	326
Eleni Yiasemides Australia	5	118 0.6×	76 1.3×	33 0.8×	60 1.7×	9 0.3×	6	262
Aleksandra Jaksic Australia	6	210 1.0×	61 1.1×	33 0.8×	41 1.1×	12 0.4×	6	387
R.C.M. Kiekens Netherlands	10	246 1.1×	69 1.2×	40 1.0×	82 2.3×	14 0.4×	10	526
Kees L.H. Guikers Netherlands	6	203 0.9×	43 0.8×	33 0.8×	73 2.0×	22 0.6×	7	327

Countries citing papers authored by C. Irwin

Since Specialization

Citations

This map shows the geographic impact of C. Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Irwin more than expected).

Fields of papers citing papers by C. Irwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Irwin. The network helps show where C. Irwin may publish in the future.

Co-authorship network of co-authors of C. Irwin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Irwin. A scholar is included among the top collaborators of C. Irwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Irwin. C. Irwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Yoo, Jung‐Wan, et al.. (2019). Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma. British Journal of Dermatology. 182(3). 799–800. 9 indexed citations

Molloy, Kevin, Jungmin Yoo, Andrew Stevens, et al.. (2019). Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T‐cell lymphoma at a tertiary care centre: should we avoid chemotherapy in conditioning regimes?. British Journal of Dermatology. 182(3). 807–809. 8 indexed citations

Sawair, Faleh, Yazan Hassona, C. Irwin, et al.. (2016). p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence. Asian Pacific Journal of Cancer Prevention. 17(3). 1243–1249. 9 indexed citations

Palmer, Julia E., et al.. (2008). The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma. International Journal of Gynecological Cancer. 18(4). 692–701. 1 indexed citations

Palmer, Julia E., et al.. (2007). P53 and bcl-2 assessment in serous ovarian carcinoma. International Journal of Gynecological Cancer. 18(2). 241–248. 12 indexed citations

Palmer, Julia E., et al.. (2007). The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma. International Journal of Gynecological Cancer. 18(4). 692–701. 8 indexed citations

Lavker, Robert M., et al.. (1995). Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. Journal of the American Academy of Dermatology. 32(1). 53–62. 244 indexed citations

Irwin, C., et al.. (1993). Paediatric radiotherapy—the avoidance of late radiation damage to the growing hip. British Journal of Radiology. 66(784). 369–374. 3 indexed citations

Neal, Anthony, C. Irwin, & H. F. Hope-Stone. (1991). The role of strontium-90 beta irradiation in the management of pterygium. Clinical Oncology. 3(2). 105–109. 11 indexed citations

10.

Irwin, C. & B.S. Mantell. (1989). Reversal of vocal cord palsy by tamoxifen. Clinical Radiology. 40(2). 199–199.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact